Two cases of delayed cyclosporin absorption leading to CsA exposure higher than that predicted by C2 monitoring alone

Nephrology Dialysis Transplantation

Volumn 20, Issue 8, 2005, Pages 1745-1747

  Yu, Richard ^a   Chadban, Steven ^a   Svara, Frank ^a   Sen, Shaundeep ^a   Eris, Josette ^a  

^a ROYAL PRINCE ALFRED HOSPITAL   (Australia)

Author keywords

Cyclosporin

Indexed keywords

BASILIXIMAB; CYCLOSPORIN A; FELODIPINE; MYCOPHENOLIC ACID; MYCOPHENOLIC ACID 2 MORPHOLINOETHYL ESTER; PREDNISONE;

ADULT; ARTICLE; CASE REPORT; CAUCASIAN; CLINICAL FEATURE; CONTROLLED STUDY; DIARRHEA; DRUG ABSORPTION; DRUG CLEARANCE; DRUG EXPOSURE; DRUG METABOLISM; FEMALE; FEVER; FLUORESCENCE POLARIZATION IMMUNOASSAY; GLOMERULONEPHRITIS; HUMAN; HYPERTENSION; KIDNEY ALLOGRAFT REJECTION; KIDNEY FAILURE; KIDNEY GRAFT REJECTION; KIDNEY TRANSPLANTATION; MALAISE; MALE; MICROEMULSION; NAUSEA; PREDICTION; PRIORITY JOURNAL; REFLUX NEPHROPATHY; SPINA BIFIDA; SYMPTOMATOLOGY; URINARY TRACT INFECTION; VOMITING;

ADULT; COMPLEMENT C2; CYCLOSPORINE; DRUG MONITORING; FEMALE; HUMANS; IMMUNOSUPPRESSIVE AGENTS; INTESTINAL ABSORPTION; KIDNEY FAILURE, CHRONIC; KIDNEY TRANSPLANTATION; MALE; MIDDLE AGED;

EID: 26444496165     PISSN: 09310509     EISSN: 14602385     Source Type: Journal    
DOI: 10.1093/ndt/gfh862     Document Type: Article

References (6)

1. Levy G. C2 Monitoring strategy for optimising cyclosporine immunosupression. BioDrugs 2001; 15: 279-290
2. Thervet E, Pfeffer P, Scolari MP et al. Clinical outcomes during the first three months post transplant in renal allograft recipients managed by C2 monitoring of cyclosporine microemulsion. Transplantation 2003; 76: 903-908
3. Levy G, Villami F, Samuel D, Sanjuan F et al. Results of Lis2t, a multicentre randomised study comparing cyclosporine microemulsion with C2 monitoring and tacrolimus with C0 monitoring in de novo liver transplantation. Transplantation 2004: 77: 1632-1638
4. Mahalati K, Belitsky P, Sketris I et al. Neoral monitoring by simplified sparse sampling area under the concentration time curve: Its relationship to acute rejection and cyclosporine nephrotoxicity early after kidney transplantation. Transplantation 1999; 68: 55-62
5. Mahalati K, Belitsky P, West K et al. Approaching the therapeutic window for cyclosporine in kidney transplantation: A prospective study. J Am Soc Nephrol 2001; 12: 823-833
6. Cole E, Midvedt K, Johnston A, Pattison J, O'Grady C. Recommendations for the implementation of neoral C2 monitoring in clinical practice. Transplantation 2002; 73: S19-S22